{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:51:35Z","timestamp":1791287495554,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"DOI":"10.1038\/s41585-026-01197-w","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:01:57Z","timestamp":1791284517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ctDNA in muscle-invasive bladder cancer \u2014 clinically actionable, not yet standardized"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4185-2475","authenticated-orcid":false,"given":"Daniele","family":"Raggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3379-2644","authenticated-orcid":false,"given":"Emanuele","family":"Crupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-9851","authenticated-orcid":false,"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.annonc.2025.12.018","volume":"37","author":"L Dyrskj\u00f8t","year":"2026","unstructured":"Dyrskj\u00f8t, L. et al. ctDNA-guided immunotherapy following radical cystectomy for muscle-invasive bladder cancer: results from the TOMBOLA trial. Ann. Oncol. 37, 712\u2013724 (2026).","journal-title":"Ann. Oncol."},{"key":"1197_CR2","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa2511885","volume":"393","author":"T Powles","year":"2025","unstructured":"Powles, T. et al. ctDNA-guided adjuvant atezolizumab in muscle-invasive bladder cancer. N. Engl. J. Med. 393, 2395\u20132408 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","volume":"595","author":"T Powles","year":"2021","unstructured":"Powles, T. et al. ctDNA guiding adjuvant immunotherapy in urothelial carcinoma. Nature 595, 432\u2013437 (2021).","journal-title":"Nature"},{"key":"1197_CR4","doi-asserted-by":"publisher","first-page":"LBA632","DOI":"10.1200\/JCO.2026.44.7_suppl.LBA632","volume":"44","author":"P Ghatalia","year":"2026","unstructured":"Ghatalia, P. et al. Circulating tumor DNA (ctDNA) to guide response-adapted bladder preservation in muscle invasive bladder cancer (MIBC): integrated analysis of the RETAIN trials. J. Clin. Oncol. 44, LBA632 (2026).","journal-title":"J. Clin. Oncol."},{"key":"1197_CR5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2533449123","volume":"123","author":"MD Galsky","year":"2026","unstructured":"Galsky, M. D. et al. Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer. Proc. Natl Acad. Sci. USA 123, e2533449123 (2026).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1197_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.eururo.2024.05.014","volume":"86","author":"I Nordentoft","year":"2024","unstructured":"Nordentoft, I. et al. Whole-genome mutational analysis for tumor-informed detection of circulating tumor DNA in patients with urothelial carcinoma. Eur. Urol. 86, 301\u2013311 (2024).","journal-title":"Eur. Urol."},{"key":"1197_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1200\/JCO.2026.44.7_suppl.633","volume":"44","author":"T Powles","year":"2026","unstructured":"Powles, T. et al. Circulating tumor (ct)DNA-guided adjuvant atezolizumab (atezo) in muscle-invasive bladder cancer (MIBC): exploratory analysis of ctDNA dynamics in the IMvigor011 trial. J. Clin. Oncol. 44, 633 (2026).","journal-title":"J. Clin. Oncol."},{"key":"1197_CR8","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","volume":"386","author":"J Tie","year":"2022","unstructured":"Tie, J. et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer. N. Engl. J. Med. 386, 2261\u20132272 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1197_CR9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.18.02052","volume":"37","author":"E Christensen","year":"2019","unstructured":"Christensen, E. et al. Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma. J. Clin. Oncol. 37, 1547\u20131557 (2019).","journal-title":"J. Clin. Oncol."},{"key":"1197_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41585-025-01023-9","volume":"22","author":"SV Lindskrog","year":"2025","unstructured":"Lindskrog, S. V. et al. Circulating tumour DNA and circulating tumour cells in bladder cancer \u2014 from discovery to clinical implementation. Nat. Rev. Urol. 22, 590\u2013608 (2025).","journal-title":"Nat. Rev. Urol."},{"key":"1197_CR11","doi-asserted-by":"publisher","DOI":"10.1200\/OP-26-00311","author":"CM Lockwood","year":"2026","unstructured":"Lockwood, C. M. et al. Circulating tumor DNA testing in solid tumors and lymphoma: ASCO guideline. JCO Oncol. Pract. https:\/\/doi.org\/10.1200\/OP-26-00311 (2026).","journal-title":"JCO Oncol. Pract."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01197-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01197-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01197-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:01:57Z","timestamp":1791284517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01197-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":11,"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1038\/s41585-026-01197-w","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"6 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}